Adalimumab is a human recombinant mAb directed against the soluble and cell-bound forms of tumor necrosis factor-alpha (TNF-α). 18 It is approved for use in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, inflammatory bowel disease, and both the skin and joint manifestations of psoriasis.
Adalimumab is a human recombinant mAb directed against the soluble and cell-bound forms of tumor necrosis factor-alpha (TNF-α). 18 It is approved for use in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, inflammatory bowel disease, and both the skin and joint manifestations of psoriasis.
| Weight | 0.030 kg |
|---|---|
| Dimensions | 16.5 × 5.5 × 2.5 cm |
| Strength | 40 mg |
| Dosage | 0.8 ml |
| Treatment | Rheumatoid arthritis, Psoriasis, Ulcerative colitis & Crohn's disease |
| Pack Size | Box of 1 x PFP |
| Brand | Mabura |
| Manufacturer | Hetero Healthcare |
| Storage Temperature | Store in a refrigerator (2-8°C). Do not freeze. |
| Generic | Adalimumab 40mg/0.8ml Pre-filled Pen |
| Country of Origin | Made in India |
| Packaging | Piece |
Reviews
There are no reviews yet.